ASRT vs KEY · rev $125.0M vs P/E 13, rev $7.51B
Assertio Therapeutics Inc (ASRT) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
KeyCorp (KEY) is a banks - regional company listed on US.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
ASRT currently screens at market cap $151.5M. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the ASRT and KEY stock pages for the full models.
Not investment advice.